[Orphan drugs and metabolic disorders].

Abstract

INTRODUCTION Over the past twenty years the legal and philosophical concept of orphan diseases has developed to include the diseases with an incidence in the general population of less than 1/5,000. Treatment of these conditions, which is very specific, requires drugs which will be used by a very small number of patients and are therefore not profitable… (More)

Topics

Cite this paper

@article{MartnezPardo2001OrphanDA, title={[Orphan drugs and metabolic disorders].}, author={M. Rosa Infante Mart{\'i}nez-Pardo}, journal={Revista de neurologia}, year={2001}, volume={33 3}, pages={220-5} }